Literature DB >> 23811417

Reply to Moonan and Weis, Seaworth et al, and Nunn and Phillips.

Jotam G Pasipanodya1, Tawanda Gumbo.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23811417      PMCID： PMC3765012          DOI： 10.1093/cid/cit434

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

1.  GRADE guidelines: 3. Rating the quality of evidence.

Authors:  Howard Balshem; Mark Helfand; Holger J Schünemann; Andrew D Oxman; Regina Kunz; Jan Brozek; Gunn E Vist; Yngve Falck-Ytter; Joerg Meerpohl; Susan Norris; Gordon H Guyatt
Journal:  J Clin Epidemiol       Date:  2011-01-05       Impact factor: 6.437

2.  First do no harm--adverse events, drug intolerance, and hepatotoxicity: how can we not justify directly observed therapy for treating tuberculosis?

Authors:  Barbara J Seaworth; Lisa Y Armitige; David E Griffith
Journal:  Clin Infect Dis       Date:  2013-06-27       Impact factor: 9.079

3.  Caveat emptor? Meta-analysis of studies comparing self-observed therapy and directly observed therapy for tuberculosis.

Authors:  Patrick K Moonan; Stephen E Weis
Journal:  Clin Infect Dis       Date:  2013-06-27       Impact factor: 9.079

4.  Consequences of noncompliance for therapy efficacy and emergence of resistance in murine tuberculosis caused by the Beijing genotype of Mycobacterium tuberculosis.

Authors:  Jurriaan E M de Steenwinkel; Marian T ten Kate; Gerjo J de Knegt; Henri A Verbrugh; Rob E Aarnoutse; Martin J Boeree; Michael A den Bakker; Dick van Soolingen; Irma A J M Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

5.  Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability.

Authors:  Shashikant Srivastava; Jotam G Pasipanodya; Claudia Meek; Richard Leff; Tawanda Gumbo
Journal:  J Infect Dis       Date:  2011-10-21       Impact factor: 5.226

6.  A meta-analysis of self-administered vs directly observed therapy effect on microbiologic failure, relapse, and acquired drug resistance in tuberculosis patients.

Authors:  Jotam G Pasipanodya; Tawanda Gumbo
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079
  6 in total
  1 in total

1.  Direct Observation of Treatment Provided by a Family Member as Compared to Non-Family Member among Children with New Tuberculosis: A Pragmatic, Non-Inferiority, Cluster-Randomized Trial in Gujarat, India.

Authors:  Paresh Vamanrao Dave; Amar Niranjan Shah; Pankaj B Nimavat; Bhavesh B Modi; Kirit R Pujara; Pradip Patel; Keshabhai Mehariya; Kiran Vaman Rade; Soma Shekar; Kuldeep S Sachdeva; John E Oeltmann; Ajay M V Kumar
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.